FDA Warning Letter — Rubix

Case 619465 — FEI 3014231143

The FDA took a Warning Letter action against Rubix on Oct 19, 2021 (Cincinnati, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Rubix
Date
Oct 19, 2021
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Cincinnati, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.